AbolerIS Pharma
PrivateLast Round
Series A
Sep 18, 2023
Total Funding Raised
$32.1M
Company Overview
AbolerIS Pharma is a biotechnology company that develops novel immunomodulatory antibodies to induce immune tolerance for treating inflammatory, autoimmune, and degenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AbolerIS Pharma Comparables
Compare AbolerIS Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Revolo Biotherapeutics | 76% | |
| NXI Therapeutics | 75% | |
| UCB | 74% | |
AbolerIS Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 18, 2023 | ||||
| Seed | Nov 4, 2020 |
AbolerIS Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series A |
| Newton Biocapital | Seed, Series A |
| Wallonie Entreprendre | Series A |
| Criteria Capital Risc | Series A |
| Sambrinvest | Series A |
| Sound Bioventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 30, 2025
Philippe Alen appointed as the new Chief Business Officer.
- Sep 18, 2023
$29.1M round led by Caixa Capital Risc
AbolerIS Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AbolerIS Pharma's valuation, stock price, and market status.